Search Results

There are 6613 results for: content related to: Progression-free survival: Does a correlation with survival justify its role as a surrogate clinical endpoint?

  1. You have free access to this content
    Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: Implications for alternative response criteria

    Cancer

    Volume 120, Issue 5, 1 March 2014, Pages: 711–721, Katherine M. Krajewski, Mizuki Nishino, Yoko Franchetti, Nikhil H. Ramaiya, Annick D. Van den Abbeele and Toni K. Choueiri

    Version of Record online : 21 NOV 2013, DOI: 10.1002/cncr.28493

  2. Diagnosis of the performance of the state-specific multireference coupled-cluster method with different truncation schemes

    Journal of Computational Chemistry

    Volume 33, Issue 14, 30 May 2012, Pages: 1285–1303, Uttam Sinha Mahapatra and Sudip Chattopadhyay

    Version of Record online : 15 MAR 2012, DOI: 10.1002/jcc.22960

  3. You have free access to this content
    Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma

    Cancer

    Volume 120, Issue 1, 1 January 2014, Pages: 52–60, Susan Halabi, Brian Rini, Bernard Escudier, Walter M. Stadler and Eric J. Small

    Version of Record online : 8 OCT 2013, DOI: 10.1002/cncr.28221

  4. You have free access to this content
    Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted therapy: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

    Cancer

    Volume 122, Issue 3, February 1, 2016, Pages: 411–419, Marina D. Kaymakcalan, Wanling Xie, Laurence Albiges, Scott A. North, Christian K. Kollmannsberger, Martin Smoragiewicz, Nils Kroeger, J. Connor Wells, Sun-Young Rha, Jae Lyun Lee, Rana R. McKay, André P. Fay, Guillermo De Velasco, Daniel Y. C. Heng and Toni K. Choueiri

    Version of Record online : 5 NOV 2015, DOI: 10.1002/cncr.29773

  5. You have free access to this content
    Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies

    Cancer

    Volume 119, Issue 18, 15 September 2013, Pages: 3377–3384, Sami Antoun, Emilie Lanoy, Roberto Iacovelli, Laurence Albiges-Sauvin, Yohann Loriot, Mansouriah Merad-Taoufik, Karim Fizazi, Mario di Palma, Vickie E. Baracos and Bernard Escudier

    Version of Record online : 25 JUN 2013, DOI: 10.1002/cncr.28218

  6. Immunotherapy for metastatic renal cell carcinoma

    Intervention Review

    The Cochrane Library

    Susanne Unverzagt, Ines Moldenhauer, Monika Nothacker, Dorothea Roßmeißl, Andreas V Hadjinicolaou, Frank Peinemann, Francesco Greco and Barbara Seliger

    Published Online : 15 MAY 2017, DOI: 10.1002/14651858.CD011673.pub2

  7. You have free access to this content
    A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1647–1655, Jorge A. Garcia, Gary R. Hudes, Toni K. Choueiri, Walter M. Stadler, Laura S. Wood, Jayne Gurtler, Shailender Bhatia, Adarsh Joshi, Rebecca R. Hozak, Yihuan Xu, Jonathan D. Schwartz and John A. Thompson

    Version of Record online : 27 FEB 2014, DOI: 10.1002/cncr.28634

  8. You have free access to this content
    A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies

    Cancer

    Volume 122, Issue 15, August 1, 2016, Pages: 2389–2398, Rana R. McKay, Guillermo De Velasco, Lillian Werner, Joaquim Bellmunt, Lauren Harshman, Christopher Sweeney, Jonathan E. Rosenberg, Michelle Hirsch, Sabina Signoretti, Eliezer M. Van Allen, Meghara Walsh, Ulka Vaishampayan, David F. McDermott and Toni K. Choueiri

    Version of Record online : 19 MAY 2016, DOI: 10.1002/cncr.30056

  9. You have free access to this content
    Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?

    Cancer

    Volume 120, Issue 11, 1 June 2014, Pages: 1604–1607, Sumanta K. Pal and Robert A. Figlin

    Version of Record online : 27 FEB 2014, DOI: 10.1002/cncr.28636

  10. You have free access to this content
    Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

    Cancer

    Volume 119, Issue 16, 15 August 2013, Pages: 2999–3006, Nils Kroeger, Wanling Xie, Jae-Lyn Lee, Georg A. Bjarnason, Jennifer J. Knox, Mary J. MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishamayan, Sun-Young Rha, Sumanta K. Pal, Takeshi Yuasa, Frede Donskov, Neeraj Agarwal, Christian K. Kollmannsberger, Min-Han Tan, Scott A. North, Brian I. Rini, Toni K. Choueiri and Daniel Y.C. Heng

    Version of Record online : 21 MAY 2013, DOI: 10.1002/cncr.28151

  11. Economic evaluation of nivolumab as a second-line treatment for advanced renal cell carcinoma from US and Chinese perspectives

    Cancer

    Volume 123, Issue 14, July 15, 2017, Pages: 2634–2641, Xiao Min Wan, Liu Bao Peng, Jin An Ma and Yuan Jian Li

    Version of Record online : 16 MAR 2017, DOI: 10.1002/cncr.30666

  12. You have free access to this content
    Abstracts

    BJU International

    Volume 114, Issue S4, October 2014, Pages: 1–18,

    Version of Record online : 21 OCT 2014, DOI: 10.1111/bju.12941

  13. State-specific multireference coupled-cluster theory

    Wiley Interdisciplinary Reviews: Computational Molecular Science

    Volume 3, Issue 2, March/April 2013, Pages: 176–197, Andreas Köhn, Matthias Hanauer, Leonie Anna Mück, Thomas-Christian Jagau and Jürgen Gauss

    Version of Record online : 16 OCT 2012, DOI: 10.1002/wcms.1120

  14. A phase 2 study of the sphingosine-1-phosphate antibody sonepcizumab in patients with metastatic renal cell carcinoma

    Cancer

    Volume 123, Issue 4, February 15, 2017, Pages: 576–582, Sumanta K. Pal, Harry A. Drabkin, James A. Reeves, John D. Hainsworth, Susan E. Hazel, Dario A. Paggiarino, Jon Wojciak, Gary Woodnutt and Rupal S. Bhatt

    Version of Record online : 11 OCT 2016, DOI: 10.1002/cncr.30393

  15. You have free access to this content
    Validation of a short questionnaire to measure symptoms and functional limitations associated with hand-foot syndrome and mucositis in patients with metastatic renal cell carcinoma

    Cancer

    Volume 122, Issue 2, January 15, 2016, Pages: 287–295, Jin-Shei Lai, Jennifer L. Beaumont, Jose Diaz, Sadya Khan and David Cella

    Version of Record online : 12 OCT 2015, DOI: 10.1002/cncr.29655

  16. You have full text access to this OnlineOpen article
    Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer

    Cancer

    Volume 120, Issue 9, 1 May 2014, Pages: 1290–1314, Brenda K. Edwards, Anne-Michelle Noone, Angela B. Mariotto, Edgar P. Simard, Francis P. Boscoe, S. Jane Henley, Ahmedin Jemal, Hyunsoon Cho, Robert N. Anderson, Betsy A. Kohler, Christie R. Eheman and Elizabeth M. Ward

    Version of Record online : 16 DEC 2013, DOI: 10.1002/cncr.28509

  17. You have free access to this content
    Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

    BJU International

    Volume 110, Issue 9, November 2012, Pages: 1289–1300, Axel Bex, Martin Gore, Peter Mulders and Cora N. Sternberg

    Version of Record online : 30 MAR 2012, DOI: 10.1111/j.1464-410X.2012.11100.x

  18. You have free access to this content
    Abstracts

    BJU International

    Volume 112, Issue S3, November 2013, Pages: 1–17,

    Version of Record online : 23 OCT 2013, DOI: 10.1111/bju.12478

  19. You have free access to this content
    Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients

    International Journal of Cancer

    Volume 109, Issue 3, 10 April 2004, Pages: 393–401, Asma Gati, Sylvie Da Rocha, Nadia Guerra, Bernard Escudier, Alessandro Moretta, Salem Chouaib, Eric Angevin and Anne Caignard

    Version of Record online : 9 JAN 2004, DOI: 10.1002/ijc.11730

  20. You have free access to this content
    Population-based cancer registries for quality-of-life research

    Cancer

    Volume 119, Issue S11, 1 June 2013, Pages: 2109–2123, Melissa S. Y. Thong, Floortje Mols, Kevin D. Stein, Tenbroeck Smith, Jan-Willem W. Coebergh and Lonneke V. van de Poll-Franse

    Version of Record online : 20 MAY 2013, DOI: 10.1002/cncr.28056